SCHEMBL19868981

SCHEMBL19868981

CC(C)Cc1ccc(-c2nc(-c3cccc(F)c3)c(-c3ccncc3)[nH]2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 13/20 0.71
MAPK13 O15264 11/20 0.71
MAPK12 P53778 11/20 0.71
MAPK11 Q15759 11/20 0.71
RAF1 P04049 3/20 0.71
ALOX5 P09917 6/20 0.58
GCGR P47871 6/20 0.57
CSNK1D P48730 2/20 0.55
PRKD3 O94806 1/20 0.55
MAP4K4 O95819 1/20 0.55
FRK P42685 1/20 0.55
MAPK9 P45984 1/20 0.55
CSNK1A1 P48729 1/20 0.55
GSK3B P49841 1/20 0.55
PTK6 Q13882 1/20 0.55
PRKD2 Q9BZL6 1/20 0.55
CLK4 Q9HAZ1 1/20 0.55
BRAF P15056 3/20 0.55
CSNK1E P49674 1/20 0.54
BRDT Q58F21 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19857273 0.88 MAPK11 (0.73) MAPK14MAPK13MAPK12MAPK11RAF1
SCHEMBL19868929 0.86 MAPK13 (0.71) MAPK14MAPK13MAPK12MAPK11RAF1
SCHEMBL19868980 0.82 MAPK14 (0.59) MAPK14MAPK13MAPK12MAPK11RAF1
SCHEMBL19868999 0.81 MAPK13 (0.68) MAPK14MAPK13MAPK12MAPK11RAF1
SCHEMBL19869000 0.81 MAPK13 (0.73) MAPK14MAPK13MAPK12MAPK11RAF1
SCHEMBL19868996 0.81 MAPK14 (0.67) MAPK14MAPK13MAPK12MAPK11RAF1
SCHEMBL19868924 0.80 BRAF (0.47) MAPK14MAPK13MAPK12MAPK11RAF1
SCHEMBL19869010 0.79 MAPK13 (0.55) MAPK14MAPK13MAPK12MAPK11RAF1
SCHEMBL19868998 0.77 ALOX5 (0.70) MAPK14MAPK13MAPK12MAPK11ALOX5
SCHEMBL19868942 0.76 MAPK14 (0.46) MAPK14MAPK13MAPK12MAPK11RAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180044316-A1 POTENTIATORS OF BETA-LACTAM ANTIBIOTICS UNIVERSITY OF NOTRE DAME DU LAC (US) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180044316-A1 POTENTIATORS OF BETA-LACTAM ANTIBIOTICS CREB1, PPP6R1, PPP1R10 MAPK14 440/4885MAPK13 782/4885MAPK12 363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.